Susquehanna Fundamental Investments LLC purchased a new stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 85,933 shares of the company's stock, valued at approximately $5,513,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Mariner LLC grew its position in shares of Ryan Specialty by 3.4% during the fourth quarter. Mariner LLC now owns 5,278 shares of the company's stock worth $339,000 after purchasing an additional 172 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in Ryan Specialty by 1.2% in the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after purchasing an additional 188 shares during the period. State of Alaska Department of Revenue grew its holdings in Ryan Specialty by 1.6% during the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock valued at $778,000 after buying an additional 190 shares in the last quarter. CIBC Asset Management Inc raised its position in shares of Ryan Specialty by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock valued at $236,000 after buying an additional 196 shares during the last quarter. Finally, Treasurer of the State of North Carolina lifted its holdings in shares of Ryan Specialty by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company's stock worth $2,887,000 after buying an additional 280 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.
Insider Buying and Selling at Ryan Specialty
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.
Ryan Specialty Trading Down 1.0 %
Shares of NYSE RYAN traded down $0.64 during trading hours on Thursday, reaching $64.87. The stock had a trading volume of 1,970,832 shares, compared to its average volume of 971,324. The business's fifty day moving average price is $70.21 and its two-hundred day moving average price is $68.77. The firm has a market cap of $16.99 billion, a price-to-earnings ratio of 94.01, a P/E/G ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a 52-week low of $48.85 and a 52-week high of $77.16. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm's quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.35 EPS. Analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a dividend of $0.12 per share. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.74%. The ex-dividend date was Tuesday, March 4th. Ryan Specialty's dividend payout ratio is currently 69.57%.
Wall Street Analyst Weigh In
A number of analysts have issued reports on RYAN shares. Barclays reduced their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Wells Fargo & Company decreased their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. UBS Group lifted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. TD Cowen started coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Finally, Royal Bank of Canada dropped their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Ryan Specialty presently has an average rating of "Hold" and a consensus price target of $75.67.
Read Our Latest Analysis on RYAN
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.